Intracellular cAMP assay and Eu-GTP-γS binding studies of chimeric opioid peptide YFa

European Journal of Pharmacology

Volumn 650, Issue 1, 2011, Pages 28-33

  Kumar, Krishan ^a,b,c   Kumar, Sambuddha ^a   Kurupati, Raj Kumar ^a   Seth, Mahesh Kumar ^a,d   Mohan, Anita ^b   Hussain, M Ejaz ^d   Pasha, Santosh ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b GURU GOBIND SINGH INDRAPRASTHA UNIVERSITY   (India)

^c UNIVERSITY OF DELHI   (India)

^d JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

Adenylyl cyclase; Antinociception; Cyclic adenosine monophosphate; Tolerance

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; DYNORPHIN A; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; FORSKOLIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; NALOXONAZINE; OPIATE PEPTIDE; PEPTIDE YFA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINOCICEPTION; ARTICLE; BINDING ASSAY; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR UPREGULATION;

AMINO ACID SEQUENCE; ANIMALS; CELL MEMBRANE; CHO CELLS; CRICETINAE; CRICETULUS; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; EUROPIUM; FORSKOLIN; GENE EXPRESSION REGULATION; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; INTRACELLULAR SPACE; OPIOID PEPTIDES; PROTEIN BINDING; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; RECOMBINANT PROTEINS; SECOND MESSENGER SYSTEMS;

EID: 78649721984     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.09.026     Document Type: Article

References (31)

1. T. Avidor-Reiss, M. Bayewitch, R. Levy, N. Matus-Leibovitch, I. Nevo, and Z. Vogel Adenylyl cyclase supersensitization in μ-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment J. Biol. Chem. 270 1995 29732 29738
2. W. Binder, H. Machelska, S. Mousa, T. Schmitt, P.J. Riviere, J.L. Junien, C. Stein, and M. Schaäfer Analgesic and anti-inflammatory effects of two novel κ- opioid peptides Anesthesiology 94 2001 1034 1044
3. N. Dietis, R. Guerrini, G. Calo, S. Salvadori, D.J. Rowbotham, and D.G. Lambert Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile Br. J. Anaesth. 103 2009 38 49
4. Mia Engström, Ale Närvanen, Juha-Matti Savola, and Siegfried Wurster Assessing activation of the human neuropeptide FF2 receptor with anon-radioactive GTP binding assay Peptides 25 2004 2099 2104
5. A.K. Finn, and J.L. Whistler Endocytosis of the μ opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal Neuron 32 2001 829 839
6. R. Franco, V. Casado, A. Cortes, J. Mallol, F. Ciruela, S. Ferre, C. Lluis, and E.I. Canela G-protein-coupled receptor heteromers: function and ligand pharmacology Br. J. Pharmacol. 153 2008 S90 S98
7. H.Z. Galina, and A.J. Kastin Existence of antiopiate system as illustrated by MIF- 1/Tyr-MIF-1 Life Sci. 39 1986 2153 2159
8. S. Gupta, S. Pasha, Y.K. Gupta, and D.K. Bhardwaj Chimeric peptide of Metenkephalin and FMRFa induces antinociception and attenuates development of tolerance to morphine antinociception Peptides 20 1999 471 478
9. A. Gupta, Fabien M. Décaillot, and A.L. Devi Targeting opioid receptor heterodimers: strategies for screening and drug development AAPS J. 8 2006 E153 E159
10. K. Gupta, I.D. Vats, Y.K. Gupta, K. Saleem, and S. Pasha Lack of tolerance and morphine-induced cross-tolerance to the analgesia of chimeric peptide of Met-enkephalin and FMRFa Peptides 29 2008 2266 2267
11. C.E. Inturrisi, J.G. Umans, D. Wolff, A.S. Stern, R.V. Lewis, S. Stein, and S. Udenfriend Analgesic activity of the naturally occurring heptapeptide met5enkephalin-Arg6-Phe7 Proc. Natl Acad. Sci. USA 81 1980 5512 5514
12. T. Koch, A. Widera, K. Bartzsch, S. Schulz, L.O. Brandenburg, N. Wundrack, A. Beyer, G. Grecksch, and V. Höllt Receptor endocytosis counteracts the development of opioid tolerance Mol. Pharmacol. 67 2005 280 287
13. G.F. Koob, and F.E. Bloom Cellular and molecular mechanisms of drug dependence Science 242 1988 715 723
14. P.Y. Law, D.S. Hom, and H.H. Loh Loss of opiate receptor activity in neuroblastoma X glioma NG108-15 hybrid cells after chronic opiate treatment. A multiple-step process Mol. Pharmacol. 22 1982 1 4
15. H.H. Loh, and A.P. Smith Molecular characterization of opioid receptors Annu. Rev. Pharmacol. Toxicol. 30 1990 123 147
16. D.K. Luttrell, and L.M. Luttrell Not so strange bedfellows: G-protein-coupled receptors and Src family kinases Ontogeny 23 2004 7969 7978
17. E.A. Majane, M.J. Iadarola, and H.-Y.T. Yang Distribution of Met5- Enkephalin-Arg6-Phe7 in rat spinal cord Brain Res. 264 1983 336 339
18. E.J. Nestler, and G.K. Aghajanian Molecular and cellular basis of addiction Science 278 1997 58 63
19. Leslie C. Newman, Steven S. Sands, David R. Wallace, and Craig W. Stevens Characterization of μ-opioid binding in amphibian whole brain tissue homogenates J. Pharmacol. Exp. Ther. 301 2002 364 370
20. K.L. Pierce, and R.J. Lefkowitz Classical and new roles of β-arrestins in the regulation of G-protein-coupled receptors Nat. Rev. Neurosci. 2 2001 727 733
21. G. Pineyro, and E. Archer-Lahlou Ligand-specific receptor states: implications for opiate receptor signalling and regulation Cell. Signal. 19 2007 8 19
22. K. Raynor, H. Kong, Y. Chen, K. Yasuda, L. Yu, G.I. Bell, and T. Reisine Pharmacological characterization of the cloned μ-, δ- and κ-opioid receptors Mol. Pharmacol. 45 1994 330 334
23. M. Roumy, C. Lorenzo, S. Mazères, S. Bouchet, J.M. Zajac, and C. Mollereau Physical association between neuropeptide FF and micro-opioid receptors as a possible molecular basis for anti-opioid activity J. Biol. Chem. 282 2007 8332 8342
24. K.S. Sharma, W.A. Klee, and M. Nirenberg Opiate-dependent modulation of adenylate cyclase Proc. Natl Acad. Sci. USA 74 1977 3365 3369
25. L.A. Snook, G. Milligan, B.L. Kieffer, and D. Massotte Co-expression of μ and delta opioid receptors as receptor-G protein fusions enhances both μ and delta signaling via distinct mechanisms J. Neurochem. 105 2008 865 873
26. M. Szucs, K. Boda, and A.R. Gintzler Dual effects of DAMGO [d-Ala2, N-Me-Phe4, Gly5-ol]-enkephalin and CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr- NH2) on adenylyl cyclase activity: implications for μ-opioid receptor Gs coupling J. Pharmacol. Exp. Ther. 310 2004 256 262
27. J. Tang, H.-Y.T. Yang, and E. Costa Inhibition of spontaneous and opiate modified nociception by an endogenous neuropeptide with Phe-Met-Arg- Phe-NH2-like immunoreactivity Proc. Natl Acad. Sci. USA 81 1984 5002 5005
28. I.D. Vats, K.S. Dolt, K. Kumar, J. Karar, M. Nath, A. Mohan, M.A. Qadar Pasha, and S. Pasha YFa, a chimeric opioid peptide, induces κ-specific antinociception with no tolerance development during 6 days of chronic treatment J. Neurosci. Res. 86 2008 1599 1607
29. M. Waldhoer, S.E. Bartlett, and J.L. Whistler Opioid receptor Annu. Rev. Biochem. 73 2004 953 990
30. H. Xu, John S. Partilla, Xiaoying Wang, John M. Rutherford, Kevin Tidgewell, Thomas E. Prisinzano, Laura M. Bohn, and Richard B. Rothman A comparison of noninternalizing (Herkinorin) and internalizing (DAMGO) m-opioid agonists on cellular markers related to opioid tolerance and dependence Synapse 61 2007 166 175
31. L. Zhang, H. Zhao, Y. Qiu, Horace H. Loh, and P.Y. Law Src phosphorylation of μ-receptor is responsible for the receptor switching from an inhibitory to a stimulatory signal J. Biol. Chem. 284 2009 1990-2000